mdgroup is proud to be the sponsor of the Christine Pierre Lifetime Achievement Award.
Named in memory of Christine Pierre, founder and president of the Society for Clinical Research Sites, and 2018 winner, the Lifetime Achievement Award is open to all clinical development industry leaders and practitioners, the award rewards those who have made a major impact on the world of clinical trials over their career; those who have influenced the direction the industry is moving in and left a legacy.
Nominations for the award and voting on the final shortlist were open to the clinical trials community, and the winner was chosen by their peers around the world.
This year’s nominees were:
- David Rogers, Director of Operations at Medicines Evaluation Unit, United Kingdom
- Danielle Giroud, CEO at MD-CLINICALS, Switzerland
- Dr Paul Glimcher, Professor at NYU Grossman School of Medicine and Chief Scientific Officer at Datacubed Health, United States
- Professor James Batchelor, Associate Dean International – Research & Enterprise, Clinical Informatics Research Unit at the University of Southampton, United Kingdom
- Dr Blanka Selecka, Early Clinical Trials Unit Manager at the University Clinical Centre, Gdansk, Poland.
On November 4 2020, at the Clinical Trials Europe virtual event, LaQuinta Jernigan, Executive Vice President at mdgroup announced this year’s winner: Dr Blanka Seklecka, Early Clinical Trials Unit Manager at the University Clinical Centre in Gdansk, Poland. In her nomination entry, it said:
“Dr Blanka Seklecka is the originator, founder and manager of the first multidisciplinary Early Clinical Trials Unit (ECTU) in Poland. She has created an internal quality system for conducting clinical trials and ECTU goes from strength to strength – after just one year of operation, ECTU has opened 23 clinical trials. Caring for the safety and effectiveness of patient treatment, the Centre cooperates with a computed tomography, magnetic resonance and positron emission tomography laboratory, a pathology laboratory with automated equipment for immunohistochemistry, a genetic laboratory with next generation sequencing and a local laboratory, where urgent tests are performed.
Thanks to Blanka, the ECTU team has knowledge of all phases of clinical trials, the guidelines of international and national governing around clinical trials, and of drug pharmacokinetics and pharmacodynamics. She has trained the team to give them the ability to identify factors affecting safety, related to the active substance, specific pharmaceutical form, administration and characteristics of the population for which the test product is intended.”
mdgroup are pleased to recognise Dr Seklecka’s great contribution to clinical research. She will shortly be receiving a glass etched trophy.
We hope that those of you who were able to attend had a great Clinical Trials Europe event despite us not being able to meet in-person, and we hope to see you all again next year.
